Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Susan Mills
Observed names:
Mills, Susan,
S.M. Mills
Institution:
Washington University in St. Louis
Observed institution:
Washington University in St. Louis
ORCID:
0000-0003-4154-7929
Observed ORCID:
0000-0003-4154-7929
OpenAlex ID:
A5018737753
Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial
2013
·
S.M. Mills
, J. Mallmann
, et al.
·
Revue Neurologique
·
139
Flexibility: Beyond the Buzzword—Practical Findings from a Systematic Literature Beview
2011
·
Jane Carthey
, Vivien Chow
, et al.
·
HERD Health Environments Research & Design Journal
·
26
Overview of dominantly inherited AD and top‐line DIAN‐TU results of solanezumab and gantenerumab
2020
·
Randall J Bateman
, Andrew J. Aschenbrenner
, et al.
·
Alzheimer s & Dementia
·
5
PDF
Solanezumab in‐depth outcomes
2020
·
Martin R. Farlow
, Randall J. Bateman
, et al.
·
Alzheimer s & Dementia
·
5
PDF
Achieving flexible & adaptable healthcare facilities - findings from a systematic literature review
2010
·
Jane Carthey
, Vivien Chow
, et al.
·
5
Gantenerumab in‐depth outcomes
2020
·
Stephen P. Salloway
, Randall J. Bateman
, et al.
·
Alzheimer s & Dementia
·
3
PDF
DIAN‐TU‐001 Trial (Tau NexGen) Rationale and Enrollment Experience
2025
·
Lon S. S Schneider
, Jorge J. Llibre‐Guerra
, et al.
·
Alzheimer s & Dementia
PDF
Fts‐03‐03: the Dian‐tu
2014
·
Randall Bateman
, Alison Goate
, et al.
·
Alzheimer s & Dementia
Erratum to “Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial” [Rev. Neurol. 169 (10) (2013) 737–743]
2013
·
S.M. Mills
, J. Mallmann
, et al.
·
Revue Neurologique
Show more works
View as search
Works count:
11
Citation count:
183
H-index:
5
I10-index:
2
Year
Topic
Type
